Personalis, Inc. (PSNL) stock
PSNLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30352% above fair value
$14.98+0.18 (+1.22%)
Close on Nov 18, 2026Market cap $1.60BP/E –Yield –
Personalis free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Personalis's free cash flow for the twelve months ending Jun 30, 2026 was -$100.98M. For fiscal 2025 it was -$79.45M. The highest annual figure on record is -$2.28M in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$79.45M | – |
| FY2024 | Dec 31, 2024 | -$46.75M | – |
| FY2023 | Dec 31, 2023 | -$67.17M | – |
| FY2022 | Dec 31, 2022 | -$120.13M | – |
| FY2021 | Dec 31, 2021 | -$81.91M | – |
| FY2020 | Dec 31, 2020 | -$45.90M | – |
| FY2019 | Dec 31, 2019 | -$26.45M | – |
| FY2018 | Dec 31, 2018 | -$2.28M | – |
| FY2017 | Dec 31, 2017 | -$4.87M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$29.55M | – |
| Q1 FY2026 | Mar 31, 2026 | -$25.67M | – |
| Q4 FY2025 | Dec 31, 2025 | -$22.32M | – |
| Q3 FY2025 | Sep 30, 2025 | -$23.43M | – |
| Q2 FY2025 | Jun 30, 2025 | -$13.23M | – |
| Q1 FY2025 | Mar 31, 2025 | -$20.47M | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.04M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.45M | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.75M | – |
| Q1 FY2024 | Mar 31, 2024 | -$20.52M | – |
| Q4 FY2023 | Dec 31, 2023 | -$16.94M | – |
| Q3 FY2023 | Sep 30, 2023 | -$17.55M | – |
| Q2 FY2023 | Jun 30, 2023 | -$13.16M | – |
| Q1 FY2023 | Mar 31, 2023 | -$19.52M | – |
| Q4 FY2022 | Dec 31, 2022 | -$26.30M | – |
| Q3 FY2022 | Sep 30, 2022 | -$36.18M | – |
| Q2 FY2022 | Jun 30, 2022 | -$37.66M | – |
| Q1 FY2022 | Mar 31, 2022 | -$19.99M | – |
| Q4 FY2021 | Dec 31, 2021 | -$18.85M | – |
| Q3 FY2021 | Sep 30, 2021 | -$20.84M | – |
| Q2 FY2021 | Jun 30, 2021 | -$30.04M | – |
| Q1 FY2021 | Mar 31, 2021 | -$12.18M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.37M | -784.8% |
| Q3 FY2020 | Sep 30, 2020 | -$17.68M | – |
| Q2 FY2020 | Jun 30, 2020 | -$16.13M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.72M | – |
| Q4 FY2019 | Dec 31, 2019 | $492.00K | -80.6% |
| Q3 FY2019 | Sep 30, 2019 | -$13.31M | – |
| Q2 FY2019 | Jun 30, 2019 | -$12.74M | – |
| Q1 FY2019 | Mar 31, 2019 | -$894.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $2.53M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.38M | – |
See a number that looks wrong?